000 | 01172 a2200349 4500 | ||
---|---|---|---|
005 | 20250513233708.0 | ||
264 | 0 | _c20010426 | |
008 | 200104s 0 0 ger d | ||
022 | _a0303-8173 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAlt, E | |
245 | 0 | 0 |
_a[Development of a radioligand assay for quantifying specific prostaglandin E1 binding in ischemic ulcers]. _h[electronic resource] |
260 |
_bActa medica Austriaca _c2000 |
||
300 |
_a152-5 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlprostadil _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIschemia _xdrug therapy |
650 | 0 | 4 |
_aLeg _xblood supply |
650 | 0 | 4 |
_aLeg Ulcer _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aRadioligand Assay |
650 | 0 | 4 |
_aReceptors, Prostaglandin E _xanalysis |
650 | 0 | 4 | _aReceptors, Prostaglandin E, EP1 Subtype |
650 | 0 | 4 | _aTreatment Outcome |
773 | 0 |
_tActa medica Austriaca _gvol. 27 _gno. 5 _gp. 152-5 |
|
999 |
_c11197717 _d11197717 |